Canada markets open in 1 hour 18 minutes

SomaLogic, Inc. (SLGCW)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.8305-0.1895 (-18.58%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.0200
Bid0.0000 x 3200
Ask1.0500 x 1000
Day's Range0.8202 - 0.9250
52 Week Range0.8202 - 0.9250
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.5330
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Simply Wall St.

    What Type Of Shareholders Own The Most Number of SomaLogic, Inc. (NASDAQ:SLGC) Shares?

    The big shareholder groups in SomaLogic, Inc. ( NASDAQ:SLGC ) have power over the company. Large companies usually have...

  • GlobeNewswire

    SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

    BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-generation precision oncology for personalized cancer therapy. As part of the agreement, OncoHost will license SomaLogic’s SomaScan® Platform to develop proteomics tests for its PROphet® diagnostic system, designed to predict patient response to immunotherapy trea

  • GlobeNewswire

    SomaLogic Announces June Conference Participation

    BOULDER, Colo., June 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following conferences. Jefferies Healthcare ConferenceJune 8-9, 2022, in New York 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics ConferenceJoe Gogain, Director, Clinical R&D will present “Bigger data = better data. Detect 7,000 proteins at once with high throughput to optimize biomarker discover” durin